Join the SOSV DEEP TECH SUMMIT, NOV 4-6. Register Today →

heXembio

Rejuvenating Human Blood Cells for Improved Healthspan

Company details

HexemBio rejuvenates aged hematopoietic stem cells to improve immune function and bone marrow transplant outcomes for hematological malignancies and overall healthspan expansion. Using a synthetic “young niche” developmental environment, it exposes a patient’s own HSCs ex vivo and returns them by standard IV infusion. The approach aims to restore stem cell performance rather than genetically or chemically reprogram cells.

In the United States, people over the age of 55 account for over 55% of healthcare spending—about $2.5 trillion annually.

heXembio Quote Image
Gabriel Levesque-Tremblay, co-founder and CEO
“This is a trillion-dollar market because we're talking about the rejuvenation of almost any adult and the potential to treat or prevent 20 diseases. We are proud to push the boundaries of possibilities in the human longevity space.”

Team

Mo Ebrahimkhani

CSO

Samira Kiani

COO

Joshua Hislop

CTO

Get In Touch with heXembio

Please tell us a little bit about yourself and why you'd like to get connected. heXembio + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.